Personalized Medicine

Most people understand that one drug does not hold a “one size fits all” promise. In fact, drug adverse reactions are one of the major reasons for hospitalizations and deaths in the U.S.  To put things in perspective approximately 100,000 deaths and 2 million hospitalizations occur each year in the United States as the result of adverse drug response. The ability to predict who will respond well to a certain drug or who may get serious side effects is a major goal of pharmacogenomic research. One can expect this promising approach to be a useful tool for individuals to predict risk benefit analysis for numerous psychiatric disorders. Despite limitations this testing still clarifies issues for many people who struggle with residual symptoms or numerous adverse effects despite good response.

At the Integrative Center for Wellness, part of your assessment and treatment planning includes pharmacogenomic testing depending on the need and risk benefit analysis. This is a simple to perform test-utilizing saliva with no cumbersome procedure or need for needles or blood draw. The test results are available in a few days to formulate a comprehensive psychopharmacological treatment plan based on genetic makeup detailing the risk for disorders, and possible response to various drugs or risk for adverse effects. This objective analysis in conjunction with clinical data helps clarify myths about the use of various medicines and prevents from shooting in the dark strategy.


  • DISEASE SPECIFIC DRUGS: Drug manufacturer’s my be able to discover drugs based on specific genes associated with particular diseases to target these cells while decreasing the damage and toxicity to healthier cells.

  • INCREASED ACCURACY: Rather then depend upon the hit and trial method, wasting valuable time and causing discomfort to the patient, physicians will be able to prescribe the right medicine at the right dose from the beginning after analyzing the genetic profile of the individual.